Literature DB >> 7073485

Trauma of the colon: early drop-back of exteriorized repair.

C V Dang, E T Peter, S N Parks, J H Ellyson.   

Abstract

Exteriorized repair of selected colonic injuries has been reported to be successful. Eighty-two colonic injuries were reviewed to determine the indications for primary repair, exteriorized repair, or colostomy and to assess the feasibility of early drop-back of the exteriorized repaired colon. Injuries were graded into three stages: stage 1, good risk; stage 2, moderate risk; and stage 3, bad risk. Sixty-seven percent of patients with stage 1 injuries underwent primary repair, 61% of patients with stage 2 injuries underwent exteriorized repair, and 61% of patients with stage 3 injuries received a colostomy. Of 38 patients who had exteriorized repair, 29 (76%) had their colon successfully dropped back on an average of five days postoperatively. Nine patients had their exteriorized colon converted to a colostomy on an average of 5.5 days postoperatively. The overall mortality was 2.4%; however, the mortality of the patients with exteriorized repair was 0%. Exteriorized repair with early drop-back is safe and economical for most patients with stage 2 injuries and selected patients with stage 3 injuries.

Entities:  

Mesh:

Year:  1982        PMID: 7073485     DOI: 10.1001/archsurg.1982.01380290098017

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

Review 1.  Current management of colon trauma.

Authors:  Robert A Maxwell; Timothy C Fabian
Journal:  World J Surg       Date:  2003-05-02       Impact factor: 3.352

2.  The influence of injury severity on complication rates after primary closure or colostomy for penetrating colon trauma.

Authors:  N Nelken; F Lewis
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

3.  Exteriorized colon anastomosis for unprepared bowel: an alternative to routine colostomy.

Authors:  Sami K Asfar; Hilal M Al-Sayer; Talib H Juma
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.